Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Molina KC"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
    Wyświetlanie 1-15 z 15
    Tytuł:
    Concomitant use of opioid medications with triptans or serotonergic antidepressants in US office-based physician visits
    Autorzy:
    Molina KC
    Fairman KA
    Sclar DA
    Pokaż więcej
    Temat:
    Serotonin Syndrome
    Opioid
    Medication Safety
    FDA Adverse Event Reporting System
    Antidepressants
    Medicine (General)
    R5-920
    Źródło:
    Drug, Healthcare and Patient Safety, Vol Volume 10, Pp 37-43 (2018)
    Opis pliku:
    electronic resource
    Relacje:
    https://www.dovepress.com/concomitant-use-of-opioid-medications-with-triptans-or-serotonergic-an-peer-reviewed-article-DHPS; https://doaj.org/toc/1179-1365
    Dostęp URL:
    https://doaj.org/article/524904d96ba948338b8468bfdd2a4e5d  Link otwiera się w nowym oknie
    Czasopismo naukowe
    Szczegóły
    Tytuł:
    Oritavancin as sequential therapy for Gram-positive bloodstream infections.
    Autorzy:
    Texidor WM; Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Science, Aurora, CO, USA.; Department of Pharmacy-Infectious Diseases, University of Colorado Hospital, Aurora, CO, USA.
    Miller MA; Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Science, Aurora, CO, USA. .; Children's Hospital Colorado, Aurora, CO, USA. .; Department of Medicine, Division of Infectious Diseases, University of Colorado School of Medicine, Aurora, CO, USA. .
    Molina KC; Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Science, Aurora, CO, USA.; Department of Pharmacy-Infectious Diseases, University of Colorado Hospital, Aurora, CO, USA.; Department of Medicine, Division of Infectious Diseases, University of Colorado School of Medicine, Aurora, CO, USA.
    Krsak M; Department of Medicine, Division of Infectious Diseases, University of Colorado School of Medicine, Aurora, CO, USA.
    Calvert B; Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Science, Aurora, CO, USA.
    Hart C; Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Science, Aurora, CO, USA.
    Storer M; Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Science, Aurora, CO, USA.
    Fish DN; Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Science, Aurora, CO, USA.
    Pokaż więcej
    Źródło:
    BMC infectious diseases [BMC Infect Dis] 2024 Jan 24; Vol. 24 (1), pp. 127. Date of Electronic Publication: 2024 Jan 24.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Endocarditis*
    Endocarditis, Bacterial*
    Acute Kidney Injury*
    Drug-Related Side Effects and Adverse Reactions*
    Vancomycin/*analogs & derivatives
    Adult ; Humans ; Male ; Middle Aged ; Aged ; Female ; Lipoglycopeptides/therapeutic use ; Retrospective Studies
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Response to Mahatanan and Kang: It's Complicated.
    Autorzy:
    Molina KC; Department of Emergency Medicine, University of Colorado School of Medicine, Aurora, Colorado, USA.; Department of Pharmacy, Scripps Health, La Jolla, California, USA.
    Mueller SW; Department of Pharmacy, University of Colorado Hospital, Aurora, Colorado, USA.; Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora, Colorado, USA.
    Miller MA; Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora, Colorado, USA.; Department of Pharmacy, Children's Hospital Colorado, Aurora, Colorado, USA.
    Krsak M; Division of Infectious Diseases, Department of Medicine, University of Colorado School of Medicine, Aurora, Colorado, USA.
    Pokaż więcej
    Źródło:
    Open forum infectious diseases [Open Forum Infect Dis] 2023 Apr 19; Vol. 10 (5), pp. ofad210. Date of Electronic Publication: 2023 Apr 19 (Print Publication: 2023).
    Typ publikacji:
    Journal Article; Comment
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Association between treatment failure and hospitalization after receipt of neutralizing monoclonal antibody treatment for COVID-19 outpatients.
    Autorzy:
    Douin DJ; Department of Anesthesiology, University of Colorado School of Medicine, 12401 E. 17th Avenue, B-215, Aurora, CO, 80045, USA. .
    Wogu AF; Department of Biostatistics and Informatics, Colorado School of Public Health, Aurora, CO, USA.
    Beaty LE; Department of Biostatistics and Informatics, Colorado School of Public Health, Aurora, CO, USA.
    Carlson NE; Department of Biostatistics and Informatics, Colorado School of Public Health, Aurora, CO, USA.; Colorado Clinical and Translational Sciences Institute, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
    Bennett TD; Colorado Clinical and Translational Sciences Institute, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.; Section of Informatics and Data Science, Department of Pediatrics, University of Colorado School of Medicine, Aurora, CO, USA.
    Aggarwal NR; Department of Medicine, University of Colorado School of Medicine, Aurora, CO, USA.
    Mayer DA; Department of Biostatistics and Informatics, Colorado School of Public Health, Aurora, CO, USA.
    Ong TC; Department of Medicine, University of Colorado School of Medicine, Aurora, CO, USA.
    Russell S; Section of Informatics and Data Science, Department of Pediatrics, University of Colorado School of Medicine, Aurora, CO, USA.
    Steele J; Research Informatics, Children's Hospital Colorado, Aurora, CO, USA.
    Peers JL; Department of Emergency Medicine, University of Colorado School of Medicine, Aurora, CO, USA.
    Molina KC; Division of Infectious Diseases, University of Colorado School of Medicine, Aurora, CO, USA.; University of Colorado School of Pharmacy and Pharmaceutical Sciences, Aurora, CO, USA.
    Wynia MK; Section of General Internal Medicine, Department of Medicine, University of Colorado School of Medicine, Aurora, CO, USA.
    Ginde AA; Colorado Clinical and Translational Sciences Institute, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.; Department of Emergency Medicine, University of Colorado School of Medicine, Aurora, CO, USA.
    Pokaż więcej
    Źródło:
    BMC infectious diseases [BMC Infect Dis] 2022 Nov 07; Vol. 22 (1), pp. 818. Date of Electronic Publication: 2022 Nov 07.
    Typ publikacji:
    Multicenter Study; Observational Study; Journal Article
    MeSH Terms:
    COVID-19*
    Humans ; Male ; Aged ; SARS-CoV-2 ; Antibodies, Neutralizing ; Outpatients ; COVID-19 Vaccines ; Hospitalization ; Obesity ; Treatment Failure ; Antibodies, Monoclonal/therapeutic use
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Comparison of Sequential Dalbavancin With Standard-of-Care Treatment for Staphylococcus aureus Bloodstream Infections.
    Autorzy:
    Molina KC; Department of Pharmacy, University of Colorado Hospital, Aurora, Colorado, USA.
    Lunowa C; Department of Pharmacy, University of Colorado Hospital, Aurora, Colorado, USA.
    Lebin M; Department of Pharmacy, University of Colorado Hospital, Aurora, Colorado, USA.
    Segerstrom Nunez A; Department of Pharmacy, University of Colorado Hospital, Aurora, Colorado, USA.
    Azimi SF; Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora, Colorado, USA.
    Krsak M; Division of Infectious Diseases, Department of Medicine, University of Colorado School of Medicine, Aurora, Colorado, USA.
    Mueller SW; Department of Pharmacy, University of Colorado Hospital, Aurora, Colorado, USA.
    Miller MA; Department of Pharmacy, University of Colorado Hospital, Aurora, Colorado, USA.
    Pokaż więcej
    Źródło:
    Open forum infectious diseases [Open Forum Infect Dis] 2022 Jul 14; Vol. 9 (7), pp. ofac335. Date of Electronic Publication: 2022 Jul 14 (Print Publication: 2022).
    Typ publikacji:
    Journal Article
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Real-World Use of Tedizolid Phosphate for 28 Days or More: A Case Series Describing Tolerability and Clinical Success.
    Autorzy:
    Morrisette T; Department of Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora, Colorado, USA.
    Molina KC; Department of Pharmacy-Infectious Diseases, University of Colorado Hospital, Aurora, Colorado, USA.
    Da Silva B; Department of Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora, Colorado, USA.
    Mueller SW; Department of Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora, Colorado, USA.
    Damioli L; Department of Medicine, University of Colorado Hospital, Aurora, Colorado, USA.
    Krsak M; Department of Medicine, University of Colorado Hospital, Aurora, Colorado, USA.
    Miller MA; Department of Pharmacy-Infectious Diseases, University of Colorado Hospital, Aurora, Colorado, USA.
    Fish DN; Department of Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora, Colorado, USA.
    Pokaż więcej
    Źródło:
    Open forum infectious diseases [Open Forum Infect Dis] 2022 May 23; Vol. 9 (6), pp. ofac028. Date of Electronic Publication: 2022 May 23 (Print Publication: 2022).
    Typ publikacji:
    Journal Article
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Carbapenemase-producing Enterobacterales in solid organ transplantation: Tip of the iceberg?
    Autorzy:
    Molina KC; Department of Pharmacy Services, University of Colorado Hospital, Aurora, Colorado, USA.; Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora, Colorado, USA.; Division of Infectious Disease, Department of Medicine, University of Colorado, Aurora, Colorado, USA.
    Bajrovic V; Division of Infectious Disease, Department of Medicine, University of Colorado, Aurora, Colorado, USA.
    Bonomo RA; Department of Medicine, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.; Louis Stokes Cleveland Department of Veterans Affairs Medical Center, Cleveland, Ohio, USA.; Departments of Pharmacology, Molecular Biology and Microbiology, Biochemistry, and Proteomics and Bioinformatics, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.; CWRU-Cleveland VAMC Center for Antimicrobial Resistance and Epidemiology (Case VA CARES), Cleveland, Ohio, USA.
    Pokaż więcej
    Źródło:
    Transplant infectious disease : an official journal of the Transplantation Society [Transpl Infect Dis] 2022 Apr; Vol. 24 (2), pp. e13780. Date of Electronic Publication: 2022 Jan 31.
    Typ publikacji:
    Letter
    MeSH Terms:
    Organ Transplantation*/adverse effects
    beta-Lactamases*/genetics
    Anti-Bacterial Agents/therapeutic use ; Bacterial Proteins/genetics ; Humans ; Klebsiella pneumoniae ; Microbial Sensitivity Tests ; Plasmids/genetics
    Opinia redakcyjna
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Kimyrsa, An Oritavancin-Containing Product: Clinical Study and Review of Properties.
    Autorzy:
    Hoover RK; Melinta Therapeutics, Dix Hills, New York, USA.
    Krsak M; University of Colorado School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
    Molina KC; University of Colorado School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.; University of Colorado Hospital, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora, Colorado, USA.
    Shah K; Metro Infectious Disease Consultants, Stockbridge, Georgia, USA.
    Redell M; Medical Affairs, Melinta Therapeutics, Morristown, New Jersey, USA.
    Pokaż więcej
    Źródło:
    Open forum infectious diseases [Open Forum Infect Dis] 2022 Mar 23; Vol. 9 (5), pp. ofac090. Date of Electronic Publication: 2022 Mar 23 (Print Publication: 2022).
    Typ publikacji:
    Journal Article
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Pharmacokinetic Evaluation of Cefazolin in the Cerebrospinal Fluid of Critically Ill Patients.
    Autorzy:
    Novak AR; Department of Pharmacy, UCHealth - University of Colorado Hospital, Aurora, Colorado, USA.
    Krsak M; Division of Infectious Diseases, Department of Medicine, University of Colorado School of Medicine, Aurora, Colorado, USA.
    Kiser TH; Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
    Neumann RT; Division of Neurosurgery, Department of Medicine, University of Colorado School of Medicine, Aurora, Colorado, USA.
    Cava Prado L; Division of Neurosurgery, Department of Medicine, University of Colorado School of Medicine, Aurora, Colorado, USA.
    Molina KC; Department of Pharmacy, UCHealth - University of Colorado Hospital, Aurora, Colorado, USA.; Division of Infectious Diseases, Department of Medicine, University of Colorado School of Medicine, Aurora, Colorado, USA.; Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
    Mueller SW; Department of Pharmacy, UCHealth - University of Colorado Hospital, Aurora, Colorado, USA.; Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA.
    Pokaż więcej
    Źródło:
    Open forum infectious diseases [Open Forum Infect Dis] 2021 Dec 25; Vol. 9 (2), pp. ofab649. Date of Electronic Publication: 2021 Dec 25 (Print Publication: 2022).
    Typ publikacji:
    Journal Article
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Real-world, Multicenter Experience With Meropenem-Vaborbactam for Gram-Negative Bacterial Infections Including Carbapenem-Resistant Enterobacterales and Pseudomonas aeruginosa .
    Autorzy:
    Alosaimy S; Anti-Infective Research Laboratory, Department of Pharmacy Practice, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, Michigan, USA.
    Lagnf AM; Anti-Infective Research Laboratory, Department of Pharmacy Practice, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, Michigan, USA.
    Morrisette T; Anti-Infective Research Laboratory, Department of Pharmacy Practice, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, Michigan, USA.
    Scipione MR; Department of Pharmacy Services, Detroit Medical Center, Detroit, Michigan, USA.
    Zhao JJ; Department of Pharmacy Services, Detroit Medical Center, Detroit, Michigan, USA.
    Jorgensen SCJ; Anti-Infective Research Laboratory, Department of Pharmacy Practice, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, Michigan, USA.; Department of Pharmacy, Mount Sinai Hospital, Toronto, Ontario, Canada.
    Mynatt R; Anti-Infective Research Laboratory, Department of Pharmacy Practice, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, Michigan, USA.; University of Kentucky, Lexington, Kentucky, USA.
    Carlson TJ; College of Pharmacy, University of Houston, Houston, Texas, USA.; Fred Wilson School of Pharmacy, High Point University, High Point, North Carolina, USA.
    Jo J; College of Pharmacy, University of Houston, Houston, Texas, USA.
    Garey KW; College of Pharmacy, University of Houston, Houston, Texas, USA.
    Allen D; Department of Pharmacy, Inova Fairfax Medical Campus, Falls Church, Virginia, USA.
    DeRonde K; Jackson Health System, Miami, Florida, USA.
    Vega AD; Jackson Health System, Miami, Florida, USA.
    Abbo LM; Jackson Health System, Miami, Florida, USA.
    Venugopalan V; College of Pharmacy, University of Florida, Gainesville, Florida, USA.
    Athans V; Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
    Saw S; Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
    Claeys KC; Department of Pharmacy Practice and Science, University of Maryland School of Pharmacy, Baltimore, Maryland, USA.
    Miller M; University of Colorado Hospital, Aurora, Colorado, USA.
    Molina KC; University of Colorado Hospital, Aurora, Colorado, USA.
    Veve M; Anti-Infective Research Laboratory, Department of Pharmacy Practice, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, Michigan, USA.; College of Pharmacy, University of Tennessee, Knoxville, Tennessee, USA.; University of Tennessee Medical Center, Knoxville, Tennessee, USA.
    Kufel WD; Binghamton University School of Pharmacy and Pharmaceutical Sciences, Binghamton, New York, USA.; State University of New York Update Medical University, Syracuse, New York, USA.
    Amaya L; Beaumont Hospital, Royal Oak, Michigan, USA.; Miami Cancer Institute, Miami, Florida, USA.
    Yost C; Beaumont Hospital, Royal Oak, Michigan, USA.
    Ortwine J; Parkland Health and Health hospital system, Dallas, Texas, USA.
    Davis SL; Anti-Infective Research Laboratory, Department of Pharmacy Practice, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, Michigan, USA.; Department of Pharmacy, Henry Ford Hospital, Detroit, Michigan, USA.
    Rybak MJ; Anti-Infective Research Laboratory, Department of Pharmacy Practice, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, Michigan, USA.; Department of Pharmacy Services, Detroit Medical Center, Detroit, Michigan, USA.; Department of Medicine, Division of Infectious Diseases, School of Medicine, Wayne State University, Detroit, Michigan, USA.
    Pokaż więcej
    Źródło:
    Open forum infectious diseases [Open Forum Infect Dis] 2021 Jul 14; Vol. 8 (8), pp. ofab371. Date of Electronic Publication: 2021 Jul 14 (Print Publication: 2021).
    Typ publikacji:
    Journal Article
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Effectiveness of Bezlotoxumab for Prevention of Recurrent Clostridioides difficile Infection Among Transplant Recipients.
    Autorzy:
    Johnson TM; Department of Pharmacy, UCHealth University of Colorado Hospital, Aurora, Colorado, USA.; Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora, Colorado, USA.
    Howard AH; Department of Pharmacy, UCHealth University of Colorado Hospital, Aurora, Colorado, USA.; Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora, Colorado, USA.
    Miller MA; Department of Pharmacy, UCHealth University of Colorado Hospital, Aurora, Colorado, USA.; Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora, Colorado, USA.
    Allen LL; Department of Medicine-Infectious Diseases, UCHealth University of Colorado Hospital, Aurora, Colorado, USA.
    Huang M; Department of Medicine-Infectious Diseases, UCHealth University of Colorado Hospital, Aurora, Colorado, USA.; Division of Infectious Diseases, University of Colorado School of Medicine, Aurora, Colorado, USA.
    Molina KC; Department of Pharmacy, UCHealth University of Colorado Hospital, Aurora, Colorado, USA.; Department of Clinical Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora, Colorado, USA.
    Bajrovic V; Department of Medicine-Infectious Diseases, UCHealth University of Colorado Hospital, Aurora, Colorado, USA.; Division of Infectious Diseases, University of Colorado School of Medicine, Aurora, Colorado, USA.
    Pokaż więcej
    Źródło:
    Open forum infectious diseases [Open Forum Infect Dis] 2021 Jun 04; Vol. 8 (7), pp. ofab294. Date of Electronic Publication: 2021 Jun 04 (Print Publication: 2021).
    Typ publikacji:
    Journal Article
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Mucormycosis in Hematopoietic Cell Transplant Recipients and in Patients With Hematological Malignancies in the Era of New Antifungal Agents.
    Autorzy:
    Miller MA; Department of Pharmacy-Infectious Diseases, University of Colorado Hospital, Denver, Colorado, USA.
    Molina KC; Department of Pharmacy-Infectious Diseases, University of Colorado Hospital, Denver, Colorado, USA.
    Gutman JA; Division of Hematology and Oncology, University of Colorado Denver, Denver, Colorado, USA.
    Scherger S; Division of Infectious Diseases, University of Colorado Denver, Denver, Colorado, USA.
    Lum JM; Department of Infectious Diseases, Respiratory Institute and Transplant Center, Cleveland Clinic Foundation, Cleveland, Ohio, USA.
    Mossad SB; Department of Infectious Diseases, Respiratory Institute and Transplant Center, Cleveland Clinic Foundation, Cleveland, Ohio, USA.
    Burgess M; Division of Infectious Diseases, University of Arkansas, Fayetteville, Arkansas, USA.
    Cheng MP; Division of Infectious Diseases, McGill University Health Centre, Montreal, Canada.; Division of Medical Microbiology, McGill University Health Centre, Montreal, Canada.
    Chuang ST; Division of Infectious Diseases, University of Rochester, Rochester, New York, USA.
    Jacobs SE; Division of Infectious Diseases, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
    Melendez DP; Division of Infectious Diseases, University of Utah, Salt Lake City, Utah, USA.
    Shah DP; Division of Infectious Diseases, University of San Antonio, San Antonio, Texas, USA.
    Zimmer A; Division of Infectious Diseases, University of Nebraska, Lincoln, Nebraska, USA.
    Sohail MR; Division of Infectious Diseases, Baylor College of Medicine, Houston, Texas, USA.
    Syed S; Division of Infectious Diseases, Mayo Clinic College of Medicine and Science, Rochester, Minnesota, USA.
    Walker RC; Division of Infectious Diseases, Mayo Clinic College of Medicine and Science, Rochester, Minnesota, USA.
    Poeschla EM; Division of Infectious Diseases, University of Colorado Denver, Denver, Colorado, USA.
    Abidi MZ; Division of Infectious Diseases, University of Colorado Denver, Denver, Colorado, USA.
    Pokaż więcej
    Źródło:
    Open forum infectious diseases [Open Forum Infect Dis] 2020 Dec 30; Vol. 8 (2), pp. ofaa646. Date of Electronic Publication: 2020 Dec 30 (Print Publication: 2021).
    Typ publikacji:
    Journal Article
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Early Experience With Eravacycline for Complicated Infections.
    Autorzy:
    Alosaimy S; Anti-Infective Research Laboratory, Department of Pharmacy Practice, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit ,Michigan, USA.
    Molina KC; University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Aurora, Colorado, USA.
    Claeys KC; Univeristy of Maryland School of Pharmacy, Baltimore, Maryland, USA.
    Andrade J; The Brooklyn Hospital Center, Brooklyn, New York, USA.
    Truong J; The Brooklyn Hospital Center, Brooklyn, New York, USA.
    King MA; Philadelphia College of Pharmacy, University of the Sciences, Philadelphia, Pennsylvania, USA.; Cooper University Hospital, Camden, New Jersey, USA.
    Pullinger BM; Philadelphia College of Pharmacy, University of the Sciences, Philadelphia, Pennsylvania, USA.; Cooper University Hospital, Camden, New Jersey, USA.
    Huang G; Univeristy of California Los Angeles, California, USA.
    Morrisette T; Anti-Infective Research Laboratory, Department of Pharmacy Practice, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit ,Michigan, USA.
    Lagnf AM; Anti-Infective Research Laboratory, Department of Pharmacy Practice, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit ,Michigan, USA.
    Davis SL; Anti-Infective Research Laboratory, Department of Pharmacy Practice, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit ,Michigan, USA.; Department of Pharmacy, Henry Ford Hospital, Detroit, Michigan, USA.
    Rybak MJ; Anti-Infective Research Laboratory, Department of Pharmacy Practice, Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit ,Michigan, USA.; Department of Pharmacy, Detroit Medical Center, Detroit, Michigan, USA.; Department of Medicine, Division of Infectious Diseases, School of Medicine, Wayne State University, Detroit, Michigan, USA.
    Pokaż więcej
    Źródło:
    Open forum infectious diseases [Open Forum Infect Dis] 2020 Mar 02; Vol. 7 (5), pp. ofaa071. Date of Electronic Publication: 2020 Mar 02 (Print Publication: 2020).
    Typ publikacji:
    Journal Article
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Melatonin potentiates running wheel-induced neurogenesis in the dentate gyrus of adult C3H/HeN mice hippocampus.
    Autorzy:
    Liu J; Department of Pharmacology & Toxicology, School of Medicine and Biomedical Sciences, University at Buffalo, Buffalo, NY 14214, USA.
    Somera-Molina KC
    Hudson RL
    Dubocovich ML
    Pokaż więcej
    Źródło:
    Journal of pineal research [J Pineal Res] 2013 Mar; Vol. 54 (2), pp. 222-31. Date of Electronic Publication: 2012 Nov 28.
    Typ publikacji:
    Journal Article; Research Support, N.I.H., Extramural
    MeSH Terms:
    Dentate Gyrus/*cytology
    Melatonin/*therapeutic use
    Neuralgia/*drug therapy
    Neurogenesis/*drug effects
    Animals ; Blotting, Western ; Enzyme-Linked Immunosorbent Assay ; Immunohistochemistry ; Mice ; Neuralgia/metabolism ; Rats, Sprague-Dawley ; p38 Mitogen-Activated Protein Kinases/antagonists & inhibitors ; p38 Mitogen-Activated Protein Kinases/metabolism
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
      Wyświetlanie 1-15 z 15

      Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies